Jefferson Life Sciences

Funding rounds backed by Jefferson Life Sciences.

Export CSV
Funding disclosed in full
$118.5M
Median round
$33.5M
Rounds in calculation
3
3 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Draig Therapeutics

Developing transformative, best-in-class neuropsychiatric therapies

$65MSeries BBiotechUnited Kingdom
12 participantsAccess BiotechnologyBritish Business BankCanaan PartnersDeep Track CapitalICGJanus Henderson InvestorsJefferson Life SciencesMarshall WaceSanofi VenturesSchroders CapitalSR OneSV Health Investors
FesariusTherapeutics

Develops FDA-cleared hydrogel dermal regeneration templates for wound healing and reconstructive surgery

$20MSeries AHealthtechUnited States
4 participantsAmerican Society of Plastic SurgeonsJefferson Life SciencesJohnson & Johnson Innovation (JJDC)NY Ventures
Juvena Therapeutics

Develops regenerative biologics to restore tissue function

$33.5MSeries BBiotechUnited States
5 participantsBison VenturesEli Lilly and CompanyJefferson Life SciencesManta RayMubadala Capital